A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis
M Soilu-Hänninen, J Åivo, BM Lindström… - Journal of Neurology …, 2012 - jnnp.bmj.com
Objectives To study the safety and efficacy of vitamin D3 as an add on therapy to interferon β-
1b (IFNB) in patients with multiple sclerosis (MS). Methods 1 year, double blind, placebo …
1b (IFNB) in patients with multiple sclerosis (MS). Methods 1 year, double blind, placebo …